IASO Cancer engagiert sich für innovative und fortschrittliche Ansätze in der Krebsbehandlung, insbesondere durch den Einsatz der dendritischen Zelltherapie (DZT). In dieser Sektion stellen wir Ihnen wissenschaftliche Publikationen und Forschungsergebnisse vor, die die Wirksamkeit und das Potenzial dieser Therapieform belegen. Unsere Forschung trägt dazu bei, die Zukunft der Krebsimmuntherapie zu gestalten und die Lebensqualität von Betroffenen nachhaltig zu verbessern.
Cookie | Dauer | Beschreibung |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |